Ocular Surface Disease

In this new blog series, I’ll be covering a range of topics related to glaucoma management. In my first blog post, I’d like to address the intersection of two of the most common conditions we manage in our practices: glaucoma and ocular surface disease.

In the previous installment, we reviewed our diagnostic approach for complex corneas stemming from dry eye, “lumps and bumps” and ectasia. Here we move into preparing these patients for surgery and intraoperative considerations.

TearClear has filed an investigational new drug application for its glaucoma drop candidate.

LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Daniel Chang, MD, discusses the impact properly preparing the ocular surface can have on cataract surgery.

At this year’s Vision Expo East, Justin A. Schweitzer, OD, FAAO, provided an overview of upcoming drug-delivery systems for glaucoma and their potential to help patients with compliance.

A presenter at this year’s SECO meeting provided an overview of ocular complications and concerns related to fitting and wear of scleral lenses, including increased cases of ocular surface disease such as dry eye.

WAILEA, Hawaii — Dupilumab is an important treatment for patients with atopic dermatitis, but there can be ocular consequences, which themselves need treatment.

Chris Wroten, OD, presented an overview at this year’s SECO meeting covering a broad range of eye care technologies and treatments that became recently available or are quickly coming down the pipeline and may increase patient compliance.

Patients with meibomian gland dysfunction who were treated with an ointment containing selenium sulfide experienced improvement in dry eye symptoms, according to a study.

The regenerative capacity of stem cells has been of great interest in every field of medicine.